1. Home
  2. CTGO vs CLLS Comparison

CTGO vs CLLS Comparison

Compare CTGO & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contango ORE Inc.

CTGO

Contango ORE Inc.

HOLD

Current Price

$25.60

Market Cap

382.6M

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$4.15

Market Cap

384.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTGO
CLLS
Founded
2009
1999
Country
United States
France
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.6M
384.3M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
CTGO
CLLS
Price
$25.60
$4.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$41.00
$8.33
AVG Volume (30 Days)
696.7K
37.9K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
19.77
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.01
$1.33
52 Week High
$34.38
$5.48

Technical Indicators

Market Signals
Indicator
CTGO
CLLS
Relative Strength Index (RSI) 65.88 66.15
Support Level $25.47 $3.25
Resistance Level $26.58 $4.46
Average True Range (ATR) 1.37 0.22
MACD 1.12 0.12
Stochastic Oscillator 98.25 76.93

Price Performance

Historical Comparison
CTGO
CLLS

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: